Parcels delivered in armored vehicles and accompanied by armed guards. Israelis will soon be able to receive medical marijuana (cannabis) directly at home. The largest network in the country, Super-Pharm Delivery will arrange the orders. The contractor will be the courier company Hafuz, which has a license to transport medical cannabis. The service will cost customers only $8.
The service will cost customers $8. Home delivery marijuana will be available to residents of all districts, including those far from the center. The contractor will be the courier company Hafuz, which has a license to transport medical cannabis.
The delivery will cost customers $8
Delivery will take place in armored transport and accompanied by armed guards, in much the same way as jewelry or large sums of money. At the same time, Hafuz will not be able to deliver anything else from the Super-Pharma range except cannabis. In the first quarter of 2020, the service will become operational.
Super-Pharma explained that the service is subsidized in part by the network. It is clear here that they do not try to earn money from it, but only want to help sick people.
The network also explained that only those who have purchased medical cannabis or its derivatives at least once at a fixed pharmacy, issued a client card and received oral advice from pharmacists on how to use the drug correctly, will be able to benefit from delivery.
Further orders begin to accept through an answering machine. The client will have to send a copy of the identity card (theudat-zeut) and the doctor’s prescription. He will then contact a representative of Hafuz to agree on the time of delivery.
25 branches for 1000 patients
Today, therapeutic marijuana and its derivatives are available at 25 Super-Pharma branches. Currently, there are about 1000 buyers, but their numbers are increasing. It is also expected that as courier delivery increases, the network will also increase the number of departments. They plan to open 10 additional shops before the end of the year where inhabitants will also have an opportunity to buy marijuana.
Reform on the sale of medical marijuana
We would like to remind you that within the framework of the reform on sale of medical marijuana from April 20 it is possible to sell marijuana in regular pharmacies, mainly in the Super-Pharm network. The reform also includes special training for doctors who receive permission to prescribe cannabis to patients, as well as pharmacists.
With the start of the medical marijuana reform, the producers of this product expect an annual turnover of $200 million. According to Calcalist, a pilot project to sell cannabis in regular pharmacies will begin on Friday, April 20. Marijuana-based products will only be available by prescription.
At the first stage, it would be possible to sell them in about 20 pharmacies, mainly in Super Pharm branches. The reform also includes special training for doctors authorized to prescribe cannabis to patients, as well as pharmacists.
Pharmacies will have to meet the requirements set by the Ministry of Health
The Ministry of Health monitors the production and distribution of medical cannabis at all stages. There are greenhouses that grow plants, processing plants and the logistics chain for storing and delivering finished products to pharmacies.
Pharmacies will have to meet the requirements set by the Ministry of Health to get a license to sell medical marijuana and related drugs. These products will be subject to the rules for the sale of drugs.
The experts do not rule out that medical cannabis will also appear in the basket of medicines approved by the Ministry of Health. For example, patients who need this medicine will receive it at a discount.
(Featured Image by edu_castro27 )
First published in vesty, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.